Literature DB >> 18714563

Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study.

A Longatto-Filho1, C Roteli-Martins, L Hammes, D Etlinger, S M Miranda Pereira, M Erzen, M Branca, P Naud, S F M Derchain, L O Sarian, J Matos, R Gontijo, T Lima, M Y S Maeda, S Tatti, S Syrjänen, K Syrjänen.   

Abstract

PURPOSE: To compare Hybrid Capture II (HC2) in detecting high-risk (HR) HPV in patient-collected vaginal samples with those obtained using gynaecologist collected samples.
METHODS: Patients were submitted to Pap smears, visual inspection with acetic acid (VIA) and HC2 for hr-HPV.
RESULTS: A total of 1,081 HC2 tests for HR-HPV were performed: 770 (71.2%) samples were collected by a physician and 311 (28.8%) were self-collected by the patients. In detecting any cervical lesion, the sensitivity of HC2 collected by a physician was higher (92.86%) than that (37.5%) in the self-sampling group. Negative predictive value (NPV) was high for both, 99.69% and 93.75%, respectively. Using the CIN2 cutoff, performance of HC2 was significantly improved: 92.9% and 62.5%, respectively. HC2 specificity for any cervical lesion and for CIN2 or higher were close to 90% in both groups.
CONCLUSIONS: Self-sampled HPV testing is a powerful option to increase the detection of cervical lesions in women segregated from prevention programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714563

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?

Authors:  Neerja Bhatla; Lalit Dar; A Rajkumar Patro; Pankaj Kumar; Alka Kriplani; Arti Gulati; Venkateswaran K Iyer; Sandeep R Mathur; Vishnubhatla Sreenivas; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol       Date:  2009-11-20       Impact factor: 2.984

2.  Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.

Authors:  Adhemar Longatto-Filho; Paulo Naud; Sophie Fm Derchain; Cecília Roteli-Martins; Sílvio Tatti; Luciano Serpa Hammes; Luis Otavio Sarian; Mojca Eržen; Margherita Branca; Jean Carlos de Matos; Renata Gontijo; Marina Y S Maeda; Temístocles Lima; Silvano Costa; Stina Syrjänen; Kari Syrjänen
Journal:  Virchows Arch       Date:  2012-05-05       Impact factor: 4.064

3.  Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.

Authors:  Anna-Barbara Moscicki; Lea Widdice; Yifei Ma; Sepideh Farhat; Susanna Miller-Benningfield; Janet Jonte; Julie Jay; Cheryl Godwin de Medina; Evelyn Hanson; Lisa Clayton; Stephen Shiboski
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

4.  Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS Direct.

Authors:  Alex J Elliot; Cassandra Powers; Alicia Thornton; Chinelo Obi; Caterina Hill; Ian Simms; Pauline Waight; Helen Maguire; David Foord; Enid Povey; Tim Wreghitt; Nichola Goddard; Joanna Ellis; Alison Bermingham; Praveen Sebastianpillai; Angie Lackenby; Maria Zambon; David Brown; Gillian E Smith; O Noel Gill
Journal:  BMJ       Date:  2009-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.